|

ERP to Improve Functioning in Veterans With OCD

RECRUITINGN/ASponsored by VA Office of Research and Development
Actively Recruiting
PhaseN/A
SponsorVA Office of Research and Development
Started2022-10-03
Est. completion2026-05-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations18 sites

Summary

Obsessive compulsive disorder (OCD) is a debilitating psychiatric illness impacting work, social, and family functioning. Exposure and Response Prevention (ERP) is the sole evidence-based psychotherapy for OCD; however, no randomized controlled trials (RCTs) have examined the effectiveness of ERP among Veterans or individuals with both OCD and posttraumatic stress disorder (PTSD). This 4-year Hybrid Type I trial will compare outcomes of ERP to those of a control condition among Veterans with OCD. Primary and secondary aims will examine whether Veterans' functioning, quality of life, and OCD symptoms differ between the ERP and control in the full sample of Veterans with OCD, and in the half of the sample with both OCD and PTSD. The tertiary aim is to conduct a mixed-methods formative evaluation of the implementation potential of ERP in VA mental health settings.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Veterans having a primary diagnosis of Obsessive Compulsive Disorder (OCD)(50% of sample) and comorbid OCD and Post-traumatic stress disorder (PTSD) (50% of sample) who are receiving care from the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, TX; the Ralph H. Johnson VA Medical Center in Charleston, SC; the VISN 20 Clinical Resource Hub which provides telehealth services to Washington, Oregon, and Alaska: the VISN 2 Clinical Resource Hub which provides telehealth services to New Jersey, New York, and northern Pennsylvania, and the VISN 6 Clinical Resource Hub which provides telehealth services to North Carolina and Virginia.
* Willingness to participate in Exposure and Response Prevention(ERP)

Exclusion Criteria:

* Significant cognitive impairment or conditions that threaten safety (current psychosis, mania, imminent suicidality including plan or intent, and treatment-interfering moderate to severe substance use).
* Potential participants taking psychotropic medications must be on a stable dose of these medications for at least 6 weeks prior to study enrollment.

Conditions3

AnxietyComorbid Post-Traumatic Stress Disorder and OCDObsessive Compulsive Disorder (OCD)

Locations18 sites

East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
East Orange, New Jersey, 07018
Jennifer Schneider, PhD347-498-4068Jennifer.Schneider2@va.gov
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, 14215-1129
Jennifer Schneider, PhD347-498-4068Jennifer.Schneider2@va.gov
VA NY Harbor Healthcare System, New York, NY
New York, New York, 10010-5011
Jennifer Schneider, PhD347-498-4068Jennifer.Schneider2@va.gov
Northport VA Medical Center, Northport, NY
Northport, New York, 11768-2200
Jennifer Schneider, PhD347-498-4068Jennifer.Schneider2@va.gov
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904
Jennifer Schneider, PhD347-498-4068Jennifer.Schneider2@va.gov

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.